Proton Treatment Center Established in Saudi Arabia
|
By MedImaging International staff writers Posted on 15 Feb 2012 |
|
A new proton treatment facility is being equipped to provide cutting-edge cancer treatment in Riyadh (Saudi Arabia).
Varian Medical Systems (Palo Alto, CA, USA) has booked a USD 77 million order with Saudi Particle Therapy Centre, LLC to equip a new proton therapy facility at the King Fahd Medical Center (Riyadh, Saudi Arabia). Varian will equip the new center with a ProBeam system for five treatment rooms as well as two TrueBeam medical linear accelerators. Equipment delivery and installation is expected to begin in spring 2013 and patient treatments are scheduled to start in late 2014. The agreement will also include a multiyear service contract that should commence as the installation is completed.
“We are honored to have been selected to supply our equipment and software for this prestigious new facility, which will make life-saving proton therapy treatments available for the first time to cancer patients in this region,” said Tim Guertin, Varian’s chief executive officer. “This is an exciting step forward for our Varian Particle Therapy business.”
Proton therapy makes it possible to treat specific types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The technology can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.
“We believe that more and more proton centers will want to employ the full suite of Varian products and technology for radiotherapy and radiosurgery as well as particle therapy for world-class cancer treatments,” said Mr. Guertin. “The combination of these technologies based on 60 years of innovation puts Varian in a unique position to help advance clinical care for patients around the world.”
Varian is currently installing and commissioning its ProBeam system at the Scripps Proton Center near San Diego (CA, USA). The company has also been selected to provide equipment for new proton therapy centers at the University of Maryland (College Park, USA) and in Mestre (Italy). It has been recognized as the preferred provider for a new center at Emory University (Atlanta, GA, USA).
Related Links:
Varian Medical Systems
Varian Medical Systems (Palo Alto, CA, USA) has booked a USD 77 million order with Saudi Particle Therapy Centre, LLC to equip a new proton therapy facility at the King Fahd Medical Center (Riyadh, Saudi Arabia). Varian will equip the new center with a ProBeam system for five treatment rooms as well as two TrueBeam medical linear accelerators. Equipment delivery and installation is expected to begin in spring 2013 and patient treatments are scheduled to start in late 2014. The agreement will also include a multiyear service contract that should commence as the installation is completed.
“We are honored to have been selected to supply our equipment and software for this prestigious new facility, which will make life-saving proton therapy treatments available for the first time to cancer patients in this region,” said Tim Guertin, Varian’s chief executive officer. “This is an exciting step forward for our Varian Particle Therapy business.”
Proton therapy makes it possible to treat specific types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The technology can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.
“We believe that more and more proton centers will want to employ the full suite of Varian products and technology for radiotherapy and radiosurgery as well as particle therapy for world-class cancer treatments,” said Mr. Guertin. “The combination of these technologies based on 60 years of innovation puts Varian in a unique position to help advance clinical care for patients around the world.”
Varian is currently installing and commissioning its ProBeam system at the Scripps Proton Center near San Diego (CA, USA). The company has also been selected to provide equipment for new proton therapy centers at the University of Maryland (College Park, USA) and in Mestre (Italy). It has been recognized as the preferred provider for a new center at Emory University (Atlanta, GA, USA).
Related Links:
Varian Medical Systems
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Needle Guide
Ultra-Pro II
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
1.5T MRI System
uMR 670
Latest Nuclear Medicine News
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease
- Combining Amino Acid PET and MRI Imaging to Help Treat Aggressive Brain Tumors
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
MRI
view channel
Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more.jpg "Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)")
Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more
PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more
Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
Essential tremor, often called familial, idiopathic, or benign tremor, leads to uncontrollable shaking that significantly affects a person’s life. When traditional medications do not alleviate symptoms,... Read moreUltrasound
view channel.jpg "Image: The Sonic Lumen Tomography (SLT) intravascular ultrasound system has received FDA 510(k) clearance (Photo courtesy of Provisio Medical)")
Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
The current standard of care of using angiographic information is often inadequate for accurately assessing vessel size in the estimated 20 million people in the U.S. who suffer from peripheral vascular disease.... Read more
Deep Learning Advances Super-Resolution Ultrasound Imaging
Ultrasound localization microscopy (ULM) is an advanced imaging technique that offers high-resolution visualization of microvascular structures. It employs microbubbles, FDA-approved contrast agents, injected... Read more
Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
Biofilms, formed by bacteria aggregating into dense communities for protection against harsh environmental conditions, are a significant contributor to various infectious diseases. Biofilms frequently... Read more
General/Advanced Imaging
view channel
Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
Chest computed tomography (CT) is a common diagnostic tool, with approximately 15 million scans conducted each year in the United States, though many are underutilized or not fully explored.... Read more
New AI Method Captures Uncertainty in Medical Images
In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more.jpg "Image: CT coronary angiography for diagnosing coronary artery disease offers advantages over other diagnostic tests (Photo courtesy of 123RF)")
CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
Coronary artery disease (CAD), one of the leading causes of death worldwide, involves the narrowing of coronary arteries due to atherosclerosis, resulting in insufficient blood flow to the heart muscle.... Read more
Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
Alzheimer's disease (AD), a condition marked by cognitive decline and the presence of beta-amyloid (Aβ) plaques and neurofibrillary tangles in the brain, poses diagnostic challenges. Amyloid positron emission... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
